When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma. // Med. – URL: https://www.sciencedirect.com/science/article/pii/S266663402600303X?dgcid=rss_sd_all
When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma. Med. https://www.sciencedirect.com/science/article/pii/S266663402600303X?dgcid=rss_sd_all
“When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma.” Med.
@article{article58208,
title = {When the standard changes during the trial: Reflections on targeted therapy in FGFR2-rearranged cholangiocarcinoma},
journal = {Med},
url = {https://www.sciencedirect.com/science/article/pii/S266663402600303X?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...